Kincell Bio
Kincell Bio is a cell therapy development and manufacturing organization (CDMO) focused on streamlining CMC development, analytical and process development, and GMP manufacturing. They support innovative companies developing immune cell therapies, including autologous and allogeneic CAR-T, CAR-NK and CAR-M programs, and are expanding their expertise in stem cell products and iPSCs.
Funding Round:
Funding Amount: $22M
Date: 15-May-2025
Investors: NewSpring Capital, Kineticos Life Sciences, and other existing investors
Markets: Biotech, Cell Therapy, Manufacturing, Pharmaceutical
HQ: Gainesville, Florida, United States
Founded: 2023
Website: http://www.kincellbio.com
LinkedIn: https://www.linkedin.com/company/kincellbio
Crunchbase: https://www.crunchbase.com/organization/kincell-bio
Leave a Comment
Comments
No comments yet.